Volume 34 Number 2 January 15-22, 2015
Chronic Diseases
A combined genetic and clinical risk prediction model for postoperative atrial fibrillation
Kolek MJ, et al. Circ Arrhythm Electrophysiol 2015 Jan
Kolek MJ, et al. Circ Arrhythm Electrophysiol 2015 Jan
Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States
Chen CX & Hay JW Int J Cardiol 2014 Dec;181C:417-24
Chen CX & Hay JW Int J Cardiol 2014 Dec;181C:417-24
Factors associated with uptake of genetics services for hypertrophic cardiomyopathy
Khouzam A, et al. J Genet Couns 2015 Jan
Khouzam A, et al. J Genet Couns 2015 Jan
Practical guidelines for managing adults with 22q11.2 deletion syndrome
Fung WL, et al. Genet Med 2015 Jan
Fung WL, et al. Genet Med 2015 Jan
Small-scale high-throughput sequencing-based identification of new therapeutic tools in cystic fibrosis
Bonini J, et al. Genet Med 2015 Jan
Bonini J, et al. Genet Med 2015 Jan
Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
Caryn Lerman, et al. Lancet Respiratory Medicine, January 2015
Caryn Lerman, et al. Lancet Respiratory Medicine, January 2015
The doctor’s dilemma: Challenges in the diagnosis and care of homozygous familial hypercholesterolemia, by Seth Baum, J Clin Lipidology, December 2014
Patch or pills? How quickly smokers metabolize nicotine may point to most effective way to quit,Science Daily, Jan 11
How personalized medicine is changing: Alzheimer's disease, by Charlotte Huff, Genome Magazine, 2014
No hay comentarios:
Publicar un comentario